SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-24-000328
Filing Date
2024-03-01
Accepted
2024-03-01 14:28:18
Documents
16
Period of Report
2024-02-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 23413
  Complete submission text file 0001640334-24-000328.txt   170889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240229.xsd EX-101.SCH 6120
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240229_lab.xml EX-101.LAB 17349
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240229_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240229_pre.xml EX-101.PRE 13069
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240229_def.xml EX-101.DEF 5669
17 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 6095
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 24708931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)